Investment sentiment has revived in the domestic stock market, with as many as 16 stocks hitting their price limits (upper limits). Buying interest spread across various industries, extending beyond specific themes such as biotech, secondary battery materials, construction, insurance, and AI (artificial intelligence).

During the morning session on the 29th, Lotte Non-Life Insurance hit the upper limit, standing out the most among non-life insurance stocks. Bolstered by strength in the biotech sector, PoxelBio also rose to its price limit, while Daebo Magnetic joined the upper-limit ranks driven by expectations related to lithium and secondary battery materials.

Construction stocks also showed clear strength. Both Kumho Industrial and Kumho Industrial Preferred shares hit the upper limit simultaneously, while Namhwa Construction and Dongyang File also rose to their price limits, signaling a flood of capital into construction-related stocks.

In addition, numerous other stocks joined the upper-limit ranks, attracting broad market attention, including Apton, AFLW, Hwashin Precision, Burnect, Hansung Cleantech, Corpus Korea, Golfzon Holdings, Flitto, Kumho Electric, and Gangdong C&L.

The continued upward momentum across multiple sectors is interpreted as a result of not only individual positive catalysts for each stock but also the full-scale inflow of 'bargain hunting' into oversold stocks. In fact, many stocks experienced surging trading volumes, confirming a concentration of short-term supply and demand.

However, experts cautioned that stocks hitting the upper limit can see significantly expanded short-term price volatility, advising investors to take a prudent approach by carefully reviewing relevant disclosures, corporate earnings, and business progress. On this day, a total of 16 stocks recorded upper limits, demonstrating active rotational buying across sectors and improving investor sentiment.

[This article was written with AI assistance.] This article received partial support from AI in the writing process based on publicly available data, and was produced after final editing and fact-checking. This article is not intended to solicit investment, and the final judgment and responsibility for investments lie with the investor.